{
  "id": "cc981c6b8b6af69b",
  "title": "Opinion: STAT+: I\u2019m the former head of Pfizer R&D. I\u2019m very worried about biopharma\u2019s future",
  "description": "The New York Times once called John Lamattina, then Pfizer head of R&#038;D, \u201cDr. Optimistic.\u201d He\u2019s not so optimistic now.",
  "content": "The New York Times once called John Lamattina, then Pfizer head of R&#038;D, \u201cDr. Optimistic.\u201d He\u2019s not so optimistic now.",
  "source": "STAT",
  "source_url": "https://www.statnews.com/2025/12/19/pharmaceutical-industry-future-rfk-jr-trump/?utm_campaign=rss",
  "published_at": "2025-12-19T09:30:00+00:00",
  "fetched_at": "2025-12-20T00:22:03.659749+00:00",
  "category": "health_biotech",
  "subcategory": null,
  "keywords": [],
  "location": null,
  "raw_data": {
    "title": "Opinion: STAT+: I\u2019m the former head of Pfizer R&D. I\u2019m very worried about biopharma\u2019s future",
    "description": "The New York Times once called John Lamattina, then Pfizer head of R&#038;D, \u201cDr. Optimistic.\u201d He\u2019s not so optimistic now.",
    "url": "https://www.statnews.com/2025/12/19/pharmaceutical-industry-future-rfk-jr-trump/?utm_campaign=rss",
    "published": "2025-12-19T09:30:00+00:00",
    "source": "STAT"
  }
}